Currax Pharmaceuticals LLC received a warning letter from the FDA regarding a misleading ad on Google for Contrave, a weight loss drug.Original Article
Misleading Contrave Google Ad Prompts FDA Warning Letter
You may also like
A Temporary Extension for the Rare Pediatric Disease...
Survey Says 25% Of Adults In U.S Suspect They Have...
Your Child’s Bedtime Affects Their Gut Health:...
Quality, Not Quantity Of Good Cholesterol Linked To...
Atueyi Tasks Pharmacy Students on Critical Thinking
Best Oil Cleansers: Top Solutions For Deep Cleansing...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.